

"AI-driven imaging solutions for precision prostate cancer diagnosis and treatment"
Nucs AI develops advanced AI solutions that analyze medical imaging to transform prostate cancer care. Using deep learning models, the platform processes PSMA-PET/CT scans in 7 to 10 minutes to detect lesions, quantify whole-body tumor burden, and predict treatment response. Automated workflows reduce clinician workload while delivering reproducible, evidence-based reports. The technology addresses critical challenges in oncology, including rising diagnostic demand, specialist staffing shortages, and the need for personalized therapy decisions. By stratifying patients before treatment and enabling timely monitoring of disease progression, Nucs AI helps clinicians avoid ineffective treatments and deliver care guided by real data.


25
Team Members
2023
Founded
Digital Health
Sector
Hybrid
Work Environment
A healthcare system where every cancer diagnosis is supported by AI-driven imaging insights, enabling personalized treatment decisions across all care settings through standardized, evidence-based precision medicine.
At Nucs AI, our mission is to revolutionize prostate cancer treatment with AI technologies that deliver accurate, data-backed insights to physicians, improving diagnostics, streamlining workflows, and supporting personalized decisions.